KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cvs Health (CVS) Income from Non-Controlling Interests (2016 - 2025)

Cvs Health (CVS) has disclosed Income from Non-Controlling Interests for 13 consecutive years, with -$8.0 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Income from Non-Controlling Interests fell 300.0% year-over-year to -$8.0 million, compared with a TTM value of $4.0 million through Jun 2025, down 75.0%, and an annual FY2025 reading of -$40.0 million, down 42.86% over the prior year.
  • Income from Non-Controlling Interests was -$8.0 million for Q2 2025 at Cvs Health, down from $3.0 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $11.0 million in Q1 2024 and bottomed at -$11.0 million in Q3 2021.
  • Average Income from Non-Controlling Interests over 5 years is $818181.8, with a median of $1.0 million recorded in 2022.
  • The sharpest move saw Income from Non-Controlling Interests skyrocketed 500.0% in 2023, then crashed 300.0% in 2025.
  • Year by year, Income from Non-Controlling Interests stood at -$10.0 million in 2021, then skyrocketed by 200.0% to $10.0 million in 2022, then plummeted by 90.0% to $1.0 million in 2023, then plummeted by 300.0% to -$2.0 million in 2024, then plummeted by 300.0% to -$8.0 million in 2025.
  • Business Quant data shows Income from Non-Controlling Interests for CVS at -$8.0 million in Q2 2025, $3.0 million in Q1 2025, and -$2.0 million in Q2 2024.